24 October 2014 -- WHO convened a high-level emergency meeting on 23 October to look at the many complex policy issues that surround access to Ebola vaccines. Ways to ensure the fair distribution and financing of these vaccines were discussed, as well as plans for the different phases of clinical trials to be performed concurrently rather than consecutively, partnerships for expediting clinical trials, and proposals for getting all development partners moving in tandem and at the same accelerated pace.
20 October 2014 -- WHO officially declares that Nigeria is now free of Ebola virus transmission. This is a spectacular success story that shows that Ebola can be contained. The story of how Nigeria ended what many believed to be potentially the most explosive Ebola outbreak imaginable is worth telling in detail.
WHO has issued a roadmap to guide and coordinate the international response to the outbreak of the Ebola virus disease in west Africa. The roadmap aims to stop ongoing Ebola transmission worldwide within 6-9 months while rapidly managing the consequences of any further international spread. It also recognises the need to address, in parallel, the outbreak’s broader socioeconomic impact.
An integrated global alert and response system for epidemics and other public health emergencies based on strong national public health systems and capacity and an effective international system for coordinated response.
- Support Member States for the implementation of national capacities for epidemic preparedness and response in the context of the IHR(2005), including laboratory capacities and early warning alert and response systems;
- Support national and international training programmes for epidemic preparedness and response;
- Coordinate and support Member States for pandemic and seasonal influenza preparedness and response;
- Develop standardized approaches for readiness and response to major epidemic-prone diseases (e.g. meningitis, yellow fever, plague);
- Strengthen biosafety, biosecurity and readiness for outbreaks of dangerous and emerging pathogens outbreaks (e.g. SARS, viral haemorrhagic fevers); Maintain and further develop a global operational platform to support outbreak response and support regional offices in implementation at regional level.